SynthesisBMC public health2026
HBV breakthrough infection in individuals born to mothers with HBV infection: a systematic review and meta-analysis.
Synthesis in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite effective immunoprophylaxis, hepatitis B vaccine breakthrough infection (VBI) can still occur among individuals born to mothers with HBV infection. This study synthesized evidence on the incidence of post-vaccination HBV infection in this high-risk population.
methodsA systematic literature search was conducted in PubMed, Embase, Scopus, China National Knowledge Infrastructure and Wanfang Chinese databases for articles evaluating VBI in individuals born to mothers with HBV infection. The VBI was characterized by seroconversion to HBsAg and/or anti-HBc positivity at or after 2 years of age, following initial post-immunoprophylaxis HBsAg negativity. The incidence of VBI was pooled after quality assessment. The review followed PRISMA 2020 guidelines and was registered in PROSPERO (CRD420251058273).
resultsAmong 40 included studies, 37 provided HBsAg data (4,776 individuals; 24,434 person-years) and 29 reported anti-HBc (6,190 individuals; 16,663 person-years). The pooled cumulative incidence of HBsAg positivity was 0.24% (95% CI: 0.01-0.66%) and the incidence rate was 2.19 per 1,000 person-years (95% CI: 1.01-4.74). Anti-HBc positivity was higher, with a pooled cumulative positivity of 4.57% (95% CI: 2.18-7.66%) and an incidence rate of 19.69 (95% CI: 6.05-64.01) per 1,000 person-years. Subgroup analyses showed comparable HBsAg positivity between children born to mothers who were HBeAg-positive and HBeAg-negative (0.38% vs. 0.34%), while anti-HBc positivity differed markedly (6.81% vs. 0.64%). Consistently lower infection rates were observed among children who received booster immunization (HBsAg: 0.00% vs. 0.34%; anti-HBc: 0.37% vs. 3.88%), higher vaccine doses (10 µg vs. 5 µg: HBsAg 0.32% vs. 0.84%; anti-HBc 3.84% vs. 11.12%), or yeast-derived recombinant vaccines (HBsAg: 0.16% vs. 0.95%; anti-HBc: 4.50% vs. 7.95%), whereas anti-HBc positivity was higher among children older than 5 years than among those aged ≤ 5 years (9.61% vs. 2.38%).
conclusionsHBsAg positivity after successful neonatal immunoprophylaxis was rare, but the higher anti-HBc positivity suggests cumulative HBV exposure in this population, particularly among children born to HBeAg-positive mothers. Sustaining long-term protection through optimized vaccine strategies, such as timely boosters or higher postnatal dose regimens, may further reduce VBI risk in high-risk population and warrants further evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.